John Borchers
Co-Founder & Managing Director @ Decathlon Capital Partners
San Francisco Bay Area, United States
John Borchers is a venture - series unknown investor at Decathlon Capital Partners in San Francisco Bay Area focused on Software and Health Care. John Borchers is General Partner of Crescendo Ventures. Borchers joined Crescendo Ventures in 1997 and has played a leading role in developing the firm’s international presence. After spending nearly three years working in Crescendo’s London office, in 2003 he relocated to Palo Alto, where he focuses on investment opportunities in the enterpriseinfrastructure market. Borchers currently serves on the Board of Directors of Credant Technologies, Dust Networks, SealedMedia, StoneFly Networks and Transitive Corporation.Prior to joining Crescendo Ventures, Borchers worked in the data warehousing and predictive analytics fields where he held various operational roles including a two-year posting to Sydney, Australia, where he opened the first Asia Pacific office for a U.S.-based data warehousing firm. Borchers holds an M.B.A. from Harvard Business School and a B.S. from the University of Richmond.
- Total investments:
- 31
- Last investment:
- Lead investor:
- 77%
Last updated:
For AI agents: llms.txt
Industries John Borchers invests in
Stages John Borchers invests in
Countries John Borchers invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Series B
- $10M–$22M
- Venture - Series Unknown
- $3M–$3.8M
Investment Focus
Industry
- Software 6 (19%)
- Health Care 6 (19%)
- Pharmaceutical 4 (13%)
- E-Commerce 3 (10%)
- Mobile Apps 3 (10%)
Stage
- Venture - Series Unknown 10 (32%)
- Series B 4 (13%)
- Funding Round 4 (13%)
- Debt Financing 4 (13%)
- Series C 3 (10%)
Country
- United States 22 (71%)
- Spain 1 (3%)
- Canada 1 (3%)
- United Kingdom 1 (3%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Prefix
|
PreFix enables you to stop spending time worrying about your home and save 30-50% off annual maintenance costs. | Debt Financing / Aug 05, 2025 | |
Strategikon Pharma
|
Clinical Maestro™ by Strategikon Pharma is the only commercially available software platform for the end- to- end management of “clinical business operations”, which is the pharmaceutical industry vertical for planning, outsourcing and budgeting clinical trials. Biopharmaceutical companies outsource 90% of their clinical development pipelinespending billions of dollars engaging in highly complex outsourced relationships with thousands of global service providers, each using their own processes, systems and reporting structures. These sophisticated relationships require complex outsourcing strategies, demanding clinical financial planning, extensive sourcing due diligence and rigorous performance management. Currently the industry manages these activities in Excel, using labor intensive, inefficient processes, costing billions of dollars in infrastructure costs, regulatory non-compliance fines and delays to market. Clinical Maestro takes a radically different approach to the management of clinical portfolio through a transformative redesign of Excel-driven processes into end-to-end integrated workflows, breaking the communication and data integration siloes between pharma companies and their outsourcing partners. Clinical Maestro™ cases studies with leading pharmaceutical companies and CROs demonstrate savings of >80% vs. manual processes, >95% prediction accuracy for clinical study budgets and high user satisfaction and engagement. | $2.3M / Debt Financing / Jun 10, 2025 | |
Kaymbu
|
Kaymbu is the iPad-based teacher documentation system to capture the essence of classroom activities and strengthen relationships between home and school. Teachers use Kaymbu to record photos and video of important classroom activities. | Private Equity / Dec 10, 2024 | |
Cyvatar.ai
|
Cyvatar is an automated cybersecurity management platform that enables startups and small businesses to effectively deploy and maintain data security while building trust, gaining transparency, and accelerating business growth.Cybersecurity can seem overwhelming and expensive for small businesses, and many end up deferring it. Cyvatar makescybersecurity accessible, achievable, and cost-effective for our members by eliminating complex tasks with automation, centralizing their technologies, and reducing their risk, in one simple subscription. We believe businesses of every shape and size deserve access to world-class security, and we’re always ready to deliver it. Learn more and get started with effortless cybersecurity at cyvatar.ai. | Venture - Series Unknown / Sep 24, 2024 | |
CancerIQ
|
CancerIQ provides a precision prevention platform that empowers healthcare providers to engage patients, stratify risk and ensure adherence with the latest evidence-based strategies to get ahead of cancer. It offers a robust content library of evidence-based guidelines and risk models to help providers interpret data and navigate patients to theappropriate genetic testing, screening, or treatment interventions. | Private Equity / Aug 21, 2024 | |
D2 Consulting
|
D2 Consulting is a provider of commercialization services to the healthcare and life sciences industries. The company works across all stakeholders including manufacturers, payers, and channel participants to execute strategic business initiatives that ensure a successful launch, distribution, and reimbursement to maximize market impact and supportan ongoing leadership position in the marketplace. | Venture - Series Unknown / Jun 24, 2024 | |
Blue Wire
|
Blue Wire is an audio-centric media company hosting podcasts with athletes, influencers, and professional sports franchises. It acquires and launches podcasts about one team or one specific topic. The company was founded in 2018 and is headquartered in San Francisco, California, United States. | Venture - Series Unknown / Feb 20, 2024 | |
Carson Life
|
Carson Life is a natural health and beauty products company focused on the Hispanic market. Its products include offerings in the hair care, weight loss, skincare, vitamins, and rejuvenation categories.Carson Life has exclusive endorsement deals with well-known celebrities in the Hispanic market. Its products are currently sold online and throughover 7,000 stores in retailers such as Walmart, Walgreens,HEB, Target and CVS across the United States and Puerto Rico. Also, its products are sold online through its webshop and e-commerce platforms like Walmart.com, Target.com, LuckyVitamin.com, Walgreens.com, and Amazon. It was founded in 2014 by Sonia Guzman and is based in Miami, Florida. | Venture - Series Unknown / Oct 04, 2023 | |
Youtooz
|
Youtooz creates high-quality collectibles for the heroes and role models of the internet - memes, content creators, music artists, licensed IPs, and more. Our mission is to bring to life the most memorable moments and personalities that bring you joy, to proudly display on your desk at work, your shelf in your bedroom, or even in your living roomfor everyone to see.Since our launch in 2019, we’ve released more than 500 unique figures and have built an amazing community of creators, artists and fans that continue to drive our mission forward. We believe that together, we can create the joy in anything. | Sep 07, 2023 | |
|
Youtooz
|
Youtooz creates high-quality collectibles for the heroes and role models of the internet - memes, content creators, music artists, licensed IPs, and more. Our mission is to bring to life the most memorable moments and personalities that bring you joy, to proudly display on your desk at work, your shelf in your bedroom, or even in your living roomfor everyone to see.Since our launch in 2019, we’ve released more than 500 unique figures and have built an amazing community of creators, artists and fans that continue to drive our mission forward. We believe that together, we can create the joy in anything. | Debt Financing / Sep 06, 2023 | |
| See all 31 investments → | |||
Co-Investors
About Decathlon Capital Partners
Decathlon Capital Partners provides growth capital for companies seeking alternatives to traditional equity investment. Through the use of highly customized revenue-based financing solutions, Decathlon provides long-term growth capital without the dilution, loss of control and operational overhead that often comes with equity-based funding.
Decathlon Capital Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Wayne Cantwell
Co-Founder and Managing Director
|
|||
|
John Borchers
Co-Founder & Managing Director
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does John Borchers invest in?
John Borchers invests primarily in Software, Health Care and Pharmaceutical startups, most often at Venture - Series Unknown and Series B stage. Most of the 31 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is John Borchers's check size?
John Borchers typically joins rounds of $10M–$22M at Series B and $3M–$3.8M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds John Borchers participates in.
How do I contact John Borchers?
Public channels for John Borchers include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did John Borchers last invest?
The most recent investment recorded for John Borchers closed in Aug 2025. Shizune tracks 31 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
